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The 5 140 nucleotides of the mouse hepatitis virus (MHV) 5 untranslated region (5UTR) are predicted to
contain three secondary structures, stem-loop 1 (SL1), SL2, and SL4. SL1 and SL2 are required for sub-
genomic RNA synthesis. The current study focuses on SL4, which contains two base-paired regions, SL4a and
SL4b. A series of reverse genetic experiments show that SL4a is not required to be base paired. Neither the
structure, the sequence, nor the putative 8-amino-acid open reading frame (ORF) in SL4b is required for viral
replication. Viruses containing separate deletions of SL4a and SL4b are viable. However, deletion of SL4 is
lethal, and genomes carrying this deletion are defective in directing subgenomic RNA synthesis. Deletion of
131ACA133 just 3 to SL4 has a profound impact on viral replication. Viruses carrying the 131ACA133 deletion
were heterogeneous in plaque size. We isolated three viruses with second-site mutations in the 5UTR which
compensated for decreased plaque sizes, delayed growth kinetics, and lower titers associated with the
131ACA133 deletion. The second-site mutations are predicted to change either the spacing between SL1 and SL2
or that between SL2 and SL4 or to destabilize the proximal portion of SL4a in our model. A mutant constructed
by replacing SL4 with a shorter sequence-unrelated stem-loop was viable. These results suggest that the
proposed SL4 in the MHV 5UTR functions in part as a spacer element that orients SL1, SL2, and the
transcriptional regulatory sequence (TRS), and this spacer function may play an important role in directing
subgenomic RNA synthesis.
Mouse hepatitis virus (MHV) and severe acute respiratory
syndrome (SARS)-coronavirus (CoV) are closely related vi-
ruses in the genus Betacoronavirus (previously known as
“coronavirus group 2”; see http://talk.ictvonline.org/media/g
/vertebrate-2008/default.aspx) in the family Coronaviridae of
the order Nidovirales (9). The coronaviruses comprise a group
of single-stranded, positive-sense, nonsegmented, enveloped
RNA viruses. CoV RNA genomes are 25 to 31 kb, the largest
genomes of all known RNA viruses, and are infectious when
introduced into permissive cells. MHV is the most extensively
studied CoV and provides mouse models for several human
diseases, including SARS, hepatitis, and multiple sclerosis
(35).
The MHV genome is 5 capped and 3 polyadenylated and
encodes nonstructural replication-related proteins in the 5
two-thirds of the genome and structural proteins in the 3
one-third of the genome. Infected cells contain seven MHV-
specific mRNAs with coterminal 3 ends, the largest of which
is the genomic RNA (18, 33). These mRNAs all carry identical
72-nucleotide (nt) leader sequences at their 5 ends (15, 16, 18,
33). The transcriptional regulatory sequences located at the 3
end of the leader sequence (TRS-L) and also upstream of the
coding sequences for each transcriptional unit in the genome
(TRS-B [body]) act as cis-regulators of transcription (4). MHV
RNA transcription occurs in the cytoplasm. In the most widely
applied model of coronavirus transcription, discontinuous
transcription of negative-strand subgenomic RNAs from a ge-
nome-length template leads to leader-body joining (27, 30, 31,
34). These negative-strand products subsequently serve as tem-
plates for subgenomic mRNA synthesis. In an elaboration of this
model, viral and/or cellular factors bind to cis-acting RNA ele-
ments in the genomic RNA 5 untranslated region (5UTR) and
3UTR, circularizing the genome and promoting template switch-
ing by topologically enabling base pairing between TRS-L and the
nascent complementary TRS-Bs (32, 38).
The MHV RNA 5UTR and 3UTR contain cis-acting se-
quences that are presumed to fold into secondary and higher-
order structures important for RNA-RNA interactions and for
the binding of viral and cellular proteins during RNA replica-
tion and translation (2, 22, 25). The first 140 nucleotides of the
MHV genome are predicted to contain three cis-acting stem-
loops (SL), SL1, SL2, and SL4, based on a consensus second-
ary structural model of nine representative CoVs representing
all three CoV subgroups (Fig. 1A) (14, 24). Some CoVs, e.g.,
SARS-CoV and bovine coronavirus (BCoV), are also pre-
dicted to contain a third stem-loop, SL3, which folds the
TRS-L into a hairpin loop. In MHV, a plausible base pairing
scheme can be drawn which places the TRS into the loop of
SL3 as well (Fig. 1B) (5), but the stem is not predicted to be
stable at 37°C (24).
SARS-CoV SL1, SL2, and SL4 can separately replace their
corresponding MHV counterparts in the MHV genome, and
the constructed chimeric viruses are viable even though the
sequences of the MHV 5UTR and the SARS-CoV 5UTR are
significantly different (14). However, when the entire MHV
5UTR is replaced by the SARS-CoV 5UTR, the MHV chi-
mera is not viable. The MHV 5UTR SL1 has been shown to
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be functionally and structurally bipartite, and structural lability
in SL1 is required to drive the interaction between the 5UTR
and the 3UTR that stimulates subgenomic RNA synthesis
(21). SL2 contains a highly conserved pentaloop (C/U)UUG
(U/C) sequence in all nine examined CoVs (24). Subsequent
nuclear magnetic resonance (NMR) determination of the so-
lution structure and functional studies reveal that SL2 adopts
a canonical uCUYG(U)a-like tetraloop stacked on a 5-base-
pair stem with the 3 U flipped out of the loop (17, 23).
Mutational analysis demonstrates that SL2 is required for sub-
genomic RNA synthesis (23, 24).
SL4 is positioned just 3 to the leader TRS (mapping at nt 74
through 139 in MHV) and is the first proposed structural RNA
element of the 5UTR that follows the leader. It is predicted to
contain a bipartite stem-loop (SL4a and SL4b) separated by a
bulge in our model (14, 24) (Fig. 1A). Chen and Olsthoorn (5)
employed a phylogenetic approach to predict secondary struc-
tures of the 5UTR and adjacent coding sequences in all CoVs.
Their structural-phylogenetic analysis is largely consistent with
our model and predicts that the core TRS-L and the flanking
sequences are poorly structured in CoVs but strongly supports
the existence of SL4 downstream of the TRS-L (Fig. 1B). The
structure of the MHV-A59 SL4 predicted by Chen and Olst-
hoorn (5) differs primarily from SL4 in the model predicted by
our group (14, 24) in that the proximal 6 base pairs of our
predicted stem are not base paired in the Chen and Olsthoorn
model (compare Fig. 1A to B). We hypothesize that the
proposed SL4 in the MHV 5UTR functions as a cis-acting
sequence important for viral replication and viral RNA syn-
thesis. In this study, we have used a reverse genetic ap-
proach to test this hypothesis and further investigated if the
secondary structure or specific nucleotides in SL4 influence
viral replication.
MATERIALS AND METHODS
Cells and viruses. Baby hamster kidney cells expressing the MHV receptor
CEACAM1a (BHK-R) (8, 37) were originally provided by Ralph Baric (Univer-
sity of North Carolina at Chapel Hill) and maintained at 37°C and 5% CO2 in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% calf
serum, 10% tryptose phosphate broth, 800 g/ml of Geneticin (G418 sulfate;
Sigma) to select for cells expressing the MHV receptor, 100 IU/ml of penicillin,
and 100 g/ml of streptomycin. DBT cells were maintained at 37°C and 5% CO2
in DMEM supplemented with 10% calf serum. L2 cells were maintained at 37°C
and 3% CO2 in DMEM supplemented with 10% calf serum. MHV-A59-1000
(37) was used as our wild-type (WT) virus, and all mutant viruses were propa-
gated in DBT cells.
Mutagenesis and plasmid construction. Plasmid A, corresponding to the first
4,882 nt of the MHV-A59 genome, was used as a substrate for site-directed
mutagenesis (37). Mutations were introduced into the MHV 5UTR with the
QuikChange II site-directed mutagenesis kit (Stratagene) according to the man-
ufacturer’s instructions or by overlapping PCR. The sequences of the oligonu-
cleotides used for mutagenesis are available on request. Mutagenized plasmids
were sequenced between unique MluI-BamHI restriction sites to verify the
introduced mutations. The MluI-BamHI fragments containing the introduced
mutations were excised and ligated with MluI-BamHI-digested parental un-
mutagenized plasmid A to generate the plasmids used for generating mutant
viruses. The sequences of these plasmids between the MluI and BamHI sites
were all verified again by sequencing to minimize the possibility that the plasmids
used to generate virus by reverse genetics contain unintended mutations inad-
vertently introduced during mutagenesis.
Assembly of full-length MHV-A59 cDNAs and recovery of mutant viruses.
cDNAs representing the entire MHV-A59 genome, carrying either the wild-type
sequence or mutations in SL4, were constructed by sequential ligation of di-
gested and gel-purified cDNAs A to G (37). The ligated cDNA was transcribed
in vitro using the Ambion T7 mMESSAGE mMACHINE kit (Applied Biosys-
tems), as described previously (13, 37). The transcription reactions were then
electroporated into BHK-R cells that were then overlaid onto DBT cells. Cul-
tures were incubated for up to 72 h and monitored by phase microscopy for the
development of the cytopathic effect (CPE). Cultures that did not demonstrate
CPE were frozen at80°C, thawed, sonicated, and clarified, and the supernatant
was blind passaged in DBT cells. A mutation was not considered to be lethal until
at least three independent trials were performed, at least one of which was done
at 34°C and 39°C to allow for recovery of temperature-sensitive viruses. Recov-
ered viruses were plaque purified on L2 cell monolayers and propagated in DBT
cells, and their 5UTR and 3UTR were amplified by reverse transcription
(RT)-PCR and sequenced to confirm the presence of the introduced mutations
and to identify any second-site mutations that might have arisen during virus
recovery and propagation. For each mutant, usually 3 or 4 plaque-purified iso-
lates at passage 1 (P1) were selected for sequencing. If second-site mutations
were recovered from the P1 virus, serial passages P2 to P5 were performed for
the plaque-purified isolates that did not contain second-site mutations, and the
5UTR and 3UTR were sequenced at each passage level to determine when
second-site mutations present in the P5 virus became established during serial
passage. Sequences at the extreme 5 end of the 5UTR were determined by 5
rapid amplification of cDNA ends (5 RACE) as described previously (21).
Briefly, mutant plaque-purified virus isolates were propagated in DBT cells, total
RNA extracted, and then reverse transcribed using primer JM19 [A59()531-
513, ATGGCTTAACCAAGACGGC]. The cDNA products had poly(A) tails
added to their 3 ends with terminal transferase (Roche). The poly(A)-tailed RT
products were repurified using the QIAquick PCR purification kit. Two rounds
of nested PCR were performed using primers JM19 and A59()282-263 (ATG
CGTTCGGAAGCATCCAT), respectively, with the adapter primer (AP-dT17)
(GATCAGGACGTTCGTTTGAGTTTTTTTTTTTTTTTTT), and the PCR
products were gel purified and sequenced.
Plaque size determination and growth curve assays. Plaque assays were per-
formed in L2 cells as described previously (13). Plaque diameters were calculated
from 40 well-formed plaques for each virus by projecting the crystal violet-
stained monolayers alongside a millimeter-scaled ruler, and the diameters of the
projected plaques were measured. Plaque diameters were calculated after the
enlargement factor was determined by measuring the projected millimeter ruler,
thus allowing very accurate determinations of plaque diameter. Growth curves
for each recovered mutant in comparison to that of the WT virus were also
determined to establish the growth phenotype of each mutant. Triplicate wells of
DBT cells in 96-well plates were infected with mutant or wild-type viruses at a
multiplicity of infection (MOI) of 3. In experiments with low-titer viruses, an
MOI of 0.1 or 1 was used. Infected cultures were harvested at 0, 4, 8, 12, 16, and
24 h postinfection (hpi). Virus titers were determined by plaque assays. The
Kruskal-Wallis test and one-way analysis of variance (ANOVA) were used for
statistical comparisons among mutant and WT viruses. Error bars represent the
standard errors of the mean.
Detection of negative-strand genomic and subgenomic RNAs for nonviable
mutants. To determine if genome replication or subgenomic RNA transcription
was taking place in cells electroporated with nonviable mutant genomes, we
performed RT-PCR assays to detect the presence of negative-sense RNAs cor-
responding to these species. Total RNAs were extracted from cultures 4 h and
8 h postelectroporation and subsequently treated with DNase I to eliminate any
cDNA that entered cells during electroporation. The total cellular RNAs were
assayed by nested RT-PCR as described previously (13, 24) to detect negative-
FIG. 1. Predicted secondary structures of MHV A59 for the 5 first 140 nucleotides, including SL1, SL2, and SL4, in our model (14, 24) (A) and
including SL1, SL2, SL3, and SL4, in the Chen and Olsthoorn model (5) (B). The noncanonical base pairs shown at nt 94 to 117 and 96 to 115
were not present in our original model (14, 24) but were incorporated from the Chen and Olsthoorn model (5). (C) SL4-A, SL4-B, SL4-C, SL4-D,
SL4-F, SL4-G, SL4-AB, SL4-CD, SL4-FG, and SL4-H represent individual mutant viruses containing clustered point mutations in the SL4a helix.
SL4-I, SL4-J, SL4-K, and SL4-L represent the individual mutant viruses containing clustered point mutations in the SL4b helix. The lowercase
letters with bold and italic in each mutant represent the introduced mutations. These mutations are highlighted by gray shading.
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sense RNA corresponding to the genome and negative-sense subgenomic RNA3
and RNA6. Parallel reactions without an RT step to synthesize cDNA were
carried out as controls to ensure that the PCRs did not detect residual DNA
transcription templates taken up by the cells during electroporation. Previous
work utilizing in vitro transcripts containing a frameshift mutation in nsp12, the
gene encoding the RNA-dependent RNA polymerase (RdRP), indicated that
these assays were not affected by any copy-back RNAs present in the in vitro
transcription reactions (24).
RESULTS
The proximal region of SL4a is not required to be base
paired. In our model (14, 24), SL4 in MHV-A59, positioned
just 3 to the leader TRS (nt 74 through 139), is predicted to
contain a bipartite stem-loop (SL4a and SL4b) separated by a
bulge (Fig. 1A). The Chen and Olsthoorn model (5) strongly
supports the existence of SL4, but nt 74 to 79 are not paired
with nt 134 to 139 (Fig. 1B). Therefore, we initiated our inves-
tigations of SL4 by focusing on the structure and function of
SL4a. To determine the functional importance of structure and
sequence in the helical regions of SL4a (nt 74 to 86 and nt 124
to 139), 10 viruses containing clustered point mutations (Fig.
1C, SL4-A through SL4-D, SL4-F through SL4-H, SL4-AB,
SL4-CD, SL4-FG) in this region were generated as described
in Materials and Methods. These mutations were predicted to
open up the stem by separately altering the sequences on the
left side (SL4-A, SL4-C, SL4-F) or the corresponding right side
(SL4-B, SL4-D, SL4-G) of the SL4a helix or by changing the
sequences on both sides of the helix (SL4-AB, SL4-CD, SL4-
FG) while restoring canonical Watson-Crick base pairing (Fig.
1C). An additional mutant, SL4-H, changed the sequence
UAAAC at nt 76 to 80 to CGGGU. This mutation potentially
maintains base pairing via noncanonical UG base pairs while
altering the sequence in this region (Fig. 1C). All 10 mutants
were viable, and most had only small to moderate impairment
of virus replication compared to that of the WT virus as as-
sessed by plaque diameter and one-step growth curves (Fig. 2).
The mutants with the largest replication deficits among these
10 mutants were the SL4-C and SL4-D viruses, containing
mutations in the distal portion of SL4a in our model. These
viruses had somewhat smaller plaque sizes and achieved a
somewhat lower titer than the WT virus, although they grew
with kinetics similar to those of the WT (Fig. 2A and D).
However, the phenotype of the SL4-CD mutant, a mutant
predicted to maintain the secondary structure while altering
the sequences on both sides of the helix, more closely resem-
bled that of the WT virus, with plaque size and growth kinetics
essentially identical to those of the WT virus (Fig. 2A and D).
The 5 and 3UTRs of four plaque-purified isolates of each
mutant were sequenced at virus passage 1, and all contained
the desired mutations, with no other substitutions in these
regions of the genome. These results indicate that the proximal
portion of SL4a in our model (nt 75 to 79 and 134 to 138) is
likely not base paired, as proposed in the Chen and Olsthoorn
model (5), or if it is base paired, this region of SL4a (Fig. 1A
and C, mutants SL4-A, -B, -AB) has no functional significance.
The upper portion (Fig. 1A and C, mutants SL4-C, -D, -CD) of
the SL4a stem is also not required for viral replication but does
contribute to optimal viral replication independently of the
sequence.
FIG. 2. Growth phenotypes of SL4a mutant viruses. (A and B) Average plaque sizes of mutant and wild-type viruses. (C, D, and E) Growth
curves of mutant and wild-type viruses at an MOI of 3.
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Neither the structure, the sequence, nor the putative 8-amino-
acid ORF in SL4b has a critical role in viral replication. The
Brian lab has previously shown that SL4b was necessary to
continuously propagate BCoV defective interfering (DI) RNA
replicons in that mutations which disrupted this stem reduced
DI replication by greater than 99% (28). BCoV, as do most
CoVs, including MHV, contains a short intra-5UTR open
reading frame (ORF) that resides in SL4b; there is a positive
correlation between maintenance of the short intra-5UTR
ORF and maximal DI RNA accumulation in BCoV DI RNA
(28). Guided by the results obtained by the Brian lab, we
generated four mutants in SL4b (nt 91 through 120) to
investigate the requirement for SL4b in the context of the
complete genome. These mutations were predicted to desta-
bilize the SL4b stem by altering the sequences on the right side
of the SL4b helix (SL4-J) or to maintain base pairing by chang-
ing the sequences on both sides of the helix (SL4-K) (Fig. 1C).
We also constructed additional mutants with substitutions of
AUG3AGG (SL4-I) and CGCG3CUUG in the predicted
terminal loop (SL4-L) (Fig. 1C). These mutations were de-
signed to mutate the presumptive initiating methionine (SL4-I)
and to alter the amino acid sequence (SL4-L) of this ORF. In
contrast to the results obtained with the BCoV DI RNA rep-
lication system (28), the four mutant viruses that we con-
structed were viable and were only modestly impaired in their
ability to replicate, as assessed by their relative plaque sizes
and growth curves, compared to that of the WT (Fig. 3).
Sequencing of the 5 and 3UTRs of four isolates of each
mutant virus showed that each contained the desired muta-
tions with no other substitutions, with the exception of SL4-K.
For SL4-K, one of the four plaque-purified isolates contained
a second-site mutation, U60C, in addition to the introduced
substitutions, but was identical to the other three SL4-K mu-
tants in terms of plaque size, growth kinetics, and titer
achieved (data not shown). These data indicate that neither the
structure, the sequence, nor the 8-amino-acid small ORF has a
critical role in viral replication, in that none of the mutant
viruses had peak titers less than 10% of that of the WT. This
contrasts with the data obtained with a DI model replicon from
the Brian lab, where the destruction of the helix that corre-
sponds to SL4b reduced DI replication to less than 1% of that
of wild-type DI RNA (28).
Deletion of SL4 is lethal. The above-described results with
multiple mutant viruses inspired us to explore whether SL4 is
essential for MHV replication. To do this, we attempted to
recover a virus containing a deletion of the entire SL4 (nt 75 to
138). In three independent experiments, including an attempt
to recover temperature-sensitive virus by incubation at 34°C
and 39°C, viral genomes with a deletion of SL4 failed to generate
infectious virus, even after three sequential blind passages of each
electroporation. This result indicates that some as-yet-unknown
property of SL4 is required for virus replication.
To determine the RNA species that might have been gen-
erated in cells electroporated with SL4-deleted genomes, we
performed nested RT-PCR assays to detect any negative-
strand genomic RNA and negative-strand RNAs complemen-
tary to subgenomic mRNA3 and mRNA6. These RNAs serve
as templates for genomic and subgenomic mRNA synthesis
(27, 32, 38). Nested RT-PCR results showed that negative-
strand genomic RNAs were present in cells at 4 and 8 h after
electroporation with in vitro-transcribed genomes deleted in
SL4, similar to what we observed after electroporation of WT
genomes (Fig. 4A). In contrast, neither negative-strand sub-
genomic RNA3 nor RNA6 was detected in cells electroporated
FIG. 3. Growth phenotypes of SL4b mutant viruses. (A) Average
plaque sizes of mutant and wild-type viruses. (B) Growth curves of
mutant and wild-type viruses at an MOI of 3.
FIG. 4. Analysis of negative-strand genomic and subgenomic RNAs for the nonviable SL4 mutant by nested RT-PCR. (A) Negative-strand
genomic RNA synthesis. Marker, 1-kb ladder; Mock, mock-infected cells. (B) Negative-strand subgenomic RNA3 (left) and RNA6 (right).
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with in vitro-transcribed SL4-deleted genomes, whereas cells
electroporated with WT genomes contained negative-strand
subgenomic RNA3 and RNA6 at 8 h incubation (Fig. 4B). For
each sample, parallel RT-PCRs without an RT step were per-
formed to ensure that residual DNA templates taken up by the
cells during electroporation did not produce PCR signals (data
not shown). Taken together, these data show that deletion of
SL4 is lethal, and genomes carrying this deletion are defective
in directing subgenomic RNA synthesis.
Mutant viruses containing separate deletions of SL4a and
SL4b are viable. To explore the relative functional importance
of SL4a and SL4b for MHV replication, mutant viruses con-
taining separate deletions of either SL4a (nt 75 to 85 and nt
125 to 138) or SL4b (nt 92 to 119) (see Fig. 1) were con-
structed, and their replication phenotypes were examined.
Both viruses were viable but did display impaired virus repli-
cation. The average plaque size of the SL4a mutant was 53%
of that of the WT, and the plaque size of the SL4b mutant
was 62% relative to the WT plaque size (Fig. 5A). Growth
curves of these mutants revealed that although both mutants
grew with kinetics similar to those of the WT virus, the peak
titer achieved by the SL4a mutant (2.05  105 PFU/ml) was
approximately 100-fold less than that reached by the WT
(2.20  107 PFU/ml) (Fig. 5B). The titer of the SL4b
mutant (5.67  106 PFU/ml) was also depressed relative to
that of the WT virus, but this approximately 4-fold effect on
titer was much less than that observed with the SL4a mutant
(Fig. 5B). Sequencing the 5UTRs of four plaque-purified iso-
lates of each mutant virus at viral passage 1 demonstrated that
all contained the desired deletions with no other substitutions
in these regions. These results suggest that neither the pro-
posed SL4a nor SL4b is separately absolutely essential for viral
replication.
Deletion of 131ACA133 gives rise to second-site revertants in
the 5UTR. To further investigate the functional importance of
SL4a in our model, we characterized a mutant virus containing
a less extensive 3-nt deletion of 131ACA133, a predicted 3-nt
bulge in the middle of SL4a in our model (Fig. 1A) which lies
just 3 to SL4 in the Chen and Olsthoorn model (Fig. 1B). This
mutant virus, named SL4-E, was viable as expected. However,
viruses containing this bulge deletion were remarkably heter-
ogeneous in phenotype (plaque size) and in some experiments
contained second-site mutations in the 5UTR in addition to
the introduced bulge deletion (Table 1). Sequencing of the 5
and 3UTRs of eight plaque-purified isolates at passage 1 clas-
sifies the eight SL4-E mutant isolates into three groups: two
isolates (SL4-E1 and SL4-E2) contained only the desired de-
letion of the ACA bulge and formed significantly smaller
plaques than the WT (51% and 47% of that of the WT, re-
spectively); two had a five-adenosine insertion between SL1
and SL2 in addition to the bulge deletion; the remaining four
isolates contained an additional deletion of C at position 80
(C80) just opposite the 131ACA133 bulge deletion in our
model (Fig. 1). Interestingly, the six plaque-purified isolates
harboring second-site mutations formed plaques that were
only slightly smaller than the WT (from 82% to 93% of that of
FIG. 5. Growth phenotypes of SL4a, SL4b, and SL4-R mutant
viruses. (A) Average plaque sizes of SL4a and SL4b mutants and
wild-type viruses. (B) Growth curves of SL4a, SL4b, and SL4-R
mutants and wild-type viruses at an MOI of 1.
TABLE 1. Relative plaque sizes of 131ACA133 deletion-related mutantsa
Virus Intended effect of mutation on SL4 Viable Sequencing of 5UTR Plaque size SD (mm)
Relative
plaque sizeb
SL4-E1-P1 Deletion of 131ACA133 Yes Deletion of 131ACA133 1.55  0.11 0.51*
SL4-E1-P5 Deletion of 131ACA133 Yes Deletion of 131ACA133 2.67  0.10 0.88
SL4-E2-P1 Deletion of 131ACA133 Yes Deletion of 131ACA133 1.43  0.07 0.47*
SL4-E6-P1 Deletion of 131ACA133 Yes Deletion of 131ACA133 and insertion
of AAAAA
2.50  0.10 0.82
5Ainsert-SL4E Deletion of 131ACA133 and insertion
of AAAAA
Yes Deletion of 131ACA133 and insertion
of AAAAA
2.66  0.09 0.88
SL4-E8-P1 Deletion of 131ACA133 Yes Deletion of 131ACA133 and deletion
of C80
2.83  0.08 0.93
C-SL4E Deletion of 131ACA133 and deletion
of C80
Yes Deletion of 131ACA133 and deletion
of C80
2.98  0.08 0.98
SL4-E2-P3 Deletion of 131ACA133 Yes Deletion of 131ACA133 and insertion
of UCUAA
1.83  0.07 0.60*
UCUAAinsert-SL4E Deletion of 131ACA133 and insertion
of UCUAA
Yes Deletion of 131ACA133 and insertion
of UCUAA
1.94  0.10 0.64*
ACA-UGU 131ACA133 change to 131UGU133 Yes 131ACA133 change to 131UGU133 2.90  0.06 0.96
WT Yes 3.03  0.07 1.00
a This table lists only prototypical plaque isolates for each genotype.
b Asterisks represent statistical significance (P  0.001).
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the WT) (Table 1) and were significantly larger than those
formed by SL4-E1 and SL4-E2 mutant viruses containing no
second-site mutations. There were no substitutions in the
3UTR for all 8 plaque isolates. We then serially passaged
SL4-E1 and -E2 in order to determine if viruses containing
only the bulge deletion were genetically unstable, thus result-
ing in mutations with a compensatory adaptation taking over
the culture. SL4-E1 serial passages from P1 to P5 were found
to maintain the bulge deletion without additional mutations in
their 5UTRs, but the plaque sizes became significantly larger
during serial passage (Table 1; Fig. 6A). In contrast, SL4-E2
serial passages, starting with P3, acquired a UCUAA inser-
tion between SL2 and SL4 (preceding U60 or A70) while
maintaining the bulge deletion (Table 1). There were no
substitutions in the 3UTRs for these two mutant viruses at
any passage level.
Since we obtained a diverse collection of second-site muta-
tions in the 5UTR upon deletion of 131ACA133, we performed
two additional experiments starting from the assembly of the
full-length cDNA in order to determine whether the diversity
of these recovered mutant viruses was truly caused by the
deletion. Eight plaque-purified isolates were recovered in each
experiment, and their 5 and 3UTRs were sequenced. Surpris-
ingly, all 16 plaque-purified virus isolates were found to con-
tain only the desired 131ACA133 deletion with no other substi-
tutions detected in the 5 UTR, and all were characterized by
plaque sizes very similar to those observed for the SL4-E1 and
SL4-E2 viruses. Recombinant viruses (UCUAA insert-SL4E,
5A insert-SL4E, C80-SL4E) were separately generated by
constructing genomes containing these second-site mutations
in addition to the bulge deletion and confirmed by sequencing.
As anticipated, their plaque sizes and shapes were very similar
to those of the originally recovered corresponding mutant vi-
ruses (Table 1). Moreover, one additional mutant virus was
generated by changing the sequence of the bulge from
131ACA133 to UGU. Sequencing of four plaque-purified iso-
lates of this mutant confirmed the presence of the desired
UGU mutations without any additional changes in their 5 and
3UTR sequences. The plaque sizes of these mutants were
almost as large as the WT plaques (Table 1), suggesting that
any requirement for the predicted ACA bulge is not likely to
be sequence specific.
Since the titer of SL4-E1 from passage 1 was approximately
1,000-fold lower than that of the WT virus, 7  105 PFU/ml
(WT, 8.8  108 PFU/ml), we performed growth curves at an
MOI of 0.1 with mutant isolates representing the four se-
quence classes of SL4-E viruses that we recovered and with
serial passage 5 of the SL4-E1 virus (SL4-E1-P5) (Fig. 6B).
The growth curves demonstrate that all of the representative
mutants had delayed growth kinetics compared to those of the
WT, lagging by 4 h. The mutants containing second-site mu-
tations generally made up for the 4-h lag with somewhat more
rapid growth from 8 to 16 hpi. The SL4-E6-P1 (contains an
AAAAA insertion between SL1 and SL2 in addition to the
ACA bulge deletion), SL4-E8-P1 (contains a second-site C80
mutation in addition to the ACA bulge deletion), and SL4-
E1-P5 viruses grew sufficiently well in this time period to reach
near-WT titers (Fig. 6B).
SL4 can be replaced by a shorter sequence-unrelated stem-
loop. Since the viruses containing mutations designed to sys-
tematically disrupt the structure and sequence of SL4 were all
viable with relatively modest effects on virus phenotype, but
deletion of all of SL4 was lethal, we further explored whether
the requirement for SL4 for MHV replication was based on the
overall sequences or the structure of SL4. Thus, we con-
structed one additional mutant virus, SL4-R, which replaces
SL4 with a shorter sequence-unrelated helical stem capped by
a stable UUCG tetraloop (Fig. 7A). In addition, we replaced
131ACA133 with UGU. Remarkably, the SL4-R mutant virus
was viable. Sequencing of the 5 and 3UTRs of four plaque-
purified isolates revealed that all four isolates contained the
intended mutation without other sequence alterations in their
5UTRs but all exhibited plaque sizes about 50 to 60% that of
the WT virus (Fig. 7B). Two contained WT 3UTRs, while two
contained C3A substitutions at position 31226 (SL4-R-2) or
31148 (SL4-R-4). The SL4-R2 and -R4 isolates were not stud-
ied further since their plaque sizes were not significantly dif-
ferent from the SL4-R1 and -R3 isolates with WT 3UTR
sequences. We next compared the growth kinetics of the
SL4-R mutant to those of the SL4a and SL4b mutants and
the WT virus (Fig. 5B). The growth curve of the SL4-R mutant
was almost identical to that of the SL4a mutant but did not
replicate nearly as well as the WT virus and the SL4b mutant.
FIG. 6. Growth phenotypes of 131ACA133 deletion SL4-E mutant and related viruses. (A) Plaque morphologies of SL4-E1-P1 and SL4-E1-P5
mutants and wild-type viruses. (B) Growth curves of the representative mutants and wild-type viruses at an MOI of 0.1.
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DISCUSSION
The MHV RNA genome 5UTR and 3UTR contain cis-
acting sequences, folding into secondary and higher-order
structures, important for RNA-RNA interactions, for binding
of viral and/or cellular proteins during RNA replication and
translation (2, 22, 25). Therefore, mapping of RNA structures
is important to understand RNA function, and such informa-
tion is likely to assist understanding other closely related CoVs,
such as the SARS-CoV. In studies of the MHV 5UTR, our
group has previously reported that SL1 adopts a bipartite
structure that drives a 5UTR-3UTR interaction and that SL2
folds into a tetraloop structure that is required for subgenomic
RNA synthesis (21, 23, 24). In the current study, we have
performed an extensive mutational and functional analysis of
SL4, a bulged stem-loop positioned just 3 to the leader TRS
and the first proposed structural RNA element of the 5UTR
following the leader. Our mutational analysis of SL4, particu-
larly the replacement of SL4 with a sequence-unrelated stem-
loop (mutant SL4-R), supports the hypothesis that SL4 func-
tions in part as a “spacer element,” and this spacer function
plays an important role in directing subgenomic RNA synthesis
during virus replication.
SL4 in MHV-A59 is predicted to contain a bipartite stem-
loop (SL4a and SL4b) separated by a bulge (14, 24). Our
results, based on the comprehensive mutational and functional
analyses of SL4a, are consistent with the Chen and Olsthoorn
phylogenetic-based model (5), leaving nt 74 to 79 and 131 to
139 unpaired (Fig. 1A and B). However, our results with the
four SL4b mutant viruses indicate that for SL4b, neither the
structure, the sequence, nor the 8-amino-acid small ORF has a
critical role in viral replication. This is contrary to the finding
in BCoV DI RNA replication assays that these elements are
FIG. 7. Secondary structure and average plaque size of the SL4-R mutant. (A, left) The predicted secondary structures of the WT 5 140 nt
(positions 1 through 140) including SL1, SL2, and SL4 in our model (14, 24). G  32.60 kcal/mol. (A, right) The secondary structures of SL4-R
mutant (positions 1 through 105) predicted by Mfold 3.0, including SL1, SL2, and SL4, replaced by a shorter sequence-unrelated stem-loop. G 
19.70 kcal/mol. The structures in the boxes represent the corresponding replacement. (B) Average plaque sizes of the four plaque-purified
isolates of the SL4-R mutant.
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necessary to continually passage BCoV DI RNA (28, 29).
There are three possible explanations for the conflicting results
from DI assays and assays done with similar mutants in the
context of a complete viral genome. (i) By their very nature, DI
replication assays are competition assays with helper wild-type
virus and recombinant WT DI RNAs that arise during the
experiment. Thus, the DI experiments may have detected sub-
tle decreases in relative fitness in the BCoV DI RNA replica-
tion that are not detected in straightforward viral replication
assays that focus on recovering viable viruses. (ii) The func-
tional role of SL4b differs in MHV and BCoV and/or between
DI replication assays and virus replication. (iii) The full-length
RNA genome generates compensatory adaptive mutations
outside the 5UTR and 3UTR of the genome during virus
recovery and propagation, since we only sequenced the 5UTR
and adjacent nucleotides (nt 1 to 250) and 3UTR (324 nt),
whereas the entire genome is 31,357 nt. Currently, we favor the
first interpretation as the most likely explanation for the dis-
cordant results, although we cannot formally exclude the third
possibility. The competitive nature of the DI RNA assays re-
sembles in some respects competition assays between wild-type
and mutant viruses. We have previously found similar discor-
dant results with MHV DI RNAs and recombinant viruses
containing identical mutations in their 3UTRs (13).
Our data demonstrate that deletion of the entire MHV
5UTR SL4 is lethal, and the genome carrying this deletion is
defective in directing subgenomic RNA synthesis. One possible
explanation for this result is that SL4, as one of the cis-acting
elements in the 5UTR, could facilitate binding to viral and/or
cellular factors leading to the formation of a 5UTR and
3UTR complex through protein-RNA and protein-protein in-
teraction, bringing TRS-L in close proximity to the 3 end of
the genomic RNA, as described in the negative-strand discon-
tinuous transcription model defined by Zuniga et al. (38). Sub-
sequently, template switching occurs through the base pairing
between TRS-L and the nascent individually complementary
TRS-Bs. Pyrimidine tract-binding protein (PTB) has been re-
ported to bind to the pentanucleotide repeat UCUAA in the
positive-strand MHV RNA leader TRS, and heterogeneous
nuclear ribonucleoprotein A1 (hnRNP A1) binds to the neg-
ative-strand leader and the complement of the TRS-B se-
quences (6, 19, 20). MHV N protein is also known to bind with
high affinity and specificity to the TRS-L and possesses helix
unwinding properties that suggest a role in template switching
(1, 10). Another hnRNP, synaptotagmin-binding cytoplasmic
RNA-interacting protein (SYNCRIP), binds to the MHV
5UTR and to the complement of the 5UTR (7). The BCoV
nsp1-encoded protein has been determined to bind to three
cis-acting stem-loops in the 5UTR, including SLIII, which
corresponds to SL4b in our model, and to regulate viral RNA
translation and replication (3, 12). It is likely that nps1-en-
coded protein of MHV has a similar function.
Another possibility is that deletion of SL4 changes the spac-
ing between crucial cis-acting structures, SL1, and SL2 and, as
a result, the disposition of TRS-L sequences 5 to SL4 and
cis-acting elements downstream of SL4. Additionally, this mu-
tation deletes all of the sequence 3 to the core TRS that is
within the BCoV 65-nt-wide 5-proximal genomic acceptor hot
spot for discontinuous transcription demonstrated by Wu et al.
(36), possibly affecting subgenomic RNA transcription. These
two explanations are not mutually exclusive, and both effects of
the deletion might contribute to this mutant’s failure to repli-
cate.
As depicted schematically in Fig. 8 by the dotted lines, both
SL3 and the proximal portion of SL4a in our original model
are likely to be unstable, and our mutational results are most
consistent with a model in which the predominant structure is
an extended single-stranded region (nt 57 to 79) between SL2
and SL4. Our mutational analysis demonstrated that deletion
of 131ACA133 has a profound impact on viral replication (Table
1). Viruses carrying this deletion were heterogeneous in phe-
notype (plaque size) and were not genetically stable, with iso-
lation of second-site revertants in a number of places in the
5UTR, which compensates the decreased plaque sizes, de-
layed growth kinetics, and lower peak titer associated with
131ACA133 deletion. Deletion of these three nucleotides would
favor a more extended SL4a conformation by increasing the
stability of the potential SL4a helix originally predicted. This
extension of the SL4a helix would change the nucleotide spac-
ing between SL4 and the 5 stem-loop structures, such as SL1
and SL2, and any 3 cis-acting structures (3, 5, 11, 12, 29) by
converting two single-stranded regions to a helix (Fig. 8). The
second-site mutations within the 5UTR are predicted to
change either the spacing between SL1 and SL2 (insertion of
five adenosines) or the spacing between SL2 and SL4 (inser-
tion of UCUAA) or to destabilize the proximal portion of the
extended SL4a by deletion of C at position 80, creating a 1-nt
bulge, thus decreasing the stability of the helix in this region
and likely restoring a structure similar to that of the wild type.
Together, these suggest that the distance between SL4, or
elements 3 to SL4, and SL1 and/or SL2 is important for viral
replication. Interestingly, Makino and Lai showed that viruses
FIG. 8. A schematic cartoon representation of second-site muta-
tions that result upon passage of MHV harboring 131ACA133 deletion
and their effect on spacing of 5UTR stem-loop structures. Three
possible conformations are shown. Our data are most compatible with
the possibility of the lower extended single-stranded region being the
predominant conformation for the wild-type sequence. The approxi-
mate positions of second-site insertions (	) and the deletion (small )
that occur after deletion of 131ACA133 are indicated by small arrows.
Inserted nucleotides are underlined. Deletion of 131ACA133 potentially
stabilizes and extends SL4a. Note that SL3 and the extended SL4a are
both predicted to be unstable at 37°C (indicated by broken lines) and
are mutually exclusive structures. The extension of SL4a alters the
spacing between SL4 and other stem-loop structures (SL1, SL2) in the
5UTR. The position of the 5 UCUAAAC core TRS-L is indicated
with shading in the figure.
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with more than two UCUAA repeats (the number of repeats
present in wild-type MHV-A59) evolve the number of repeats
downward with serial passage (26). This is consistent with the
idea that there is an optimal spacing between SL4 and SL1. We
also isolated viruses that did not have second-site mutations in
the 5UTR but were characterized by increased plaque size
and growth curves upon subsequent serial passage; this sug-
gests the presence of a second-site mutation(s) elsewhere in
the genome outside the 5UTR and 3UTR, which reverses the
functional deficits associated with the 131ACA133 deletion. We
are in the process of sequencing the genomes of the SL4-E
mutant viruses (with and without serial passages) to search for
second-site mutations outside the 5UTR and 3UTR, in an
effort to determine the structural origin of these effects.
The MHV genome can tolerate the deletion of either SL4a or
SL4b and yield viable viruses. Replacing SL4 with a sequence-
unrelated shorter stem-loop structure (SL4-R) permits recovery
of infectious recombinant virus, providing a further indication
that the sequence of SL4 is relatively less important for virus
replication than the spacing between SL4 and other 5UTR stem-
loops. It should be noted that care was taken in constructing
SL4-R to approximate the low stability of the wild-type SL4a
structure in our original model with the extended SL4a region,
making it likely that the base pairing of the most proximal 6 bp of
the SL4-R stem (nt 74 to 79/99 to 104; Fig. 7A) will be unstable,
as we think to be the case for the wild-type SL4.
Taking the above data as a whole, we draw the conclusion that
SL4 functions as a structural spacer element that properly orients
SL1, SL2, TRS, and/or more distal structural elements of the
5UTR. A schematic model that graphically illustrates this con-
clusion is shown in Fig. 8. The current data are consistent with our
previous results in terms of SL1 and SL2 (21, 23, 24). These
cis-acting elements provide the structural motifs that are crucial
for negative-strand subgenomic RNA syntheses but are not re-
quired for full-length genomic negative-strand synthesis. Future
work directed at further determining the cis-acting structural el-
ements contained in the MHV 5UTR and the 5 end of the nsp1
coding sequences will enhance our understanding of MHV rep-
lication. We are also in an effort to investigate the interactions of
these elements with viral and/or cellular proteins to further elu-
cidate their function. Such information will assist understanding
the common replication signals in other closely related CoVs,
such as BCoV and SARS-CoV.
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